Chromatin regulation of transcriptional enhancers and cell fate by the Sotos syndrome gene NSD1.
Loading...
Embargo End Date
ICR Authors
Authors
Sun, Z
Lin, Y
Islam, MT
Koche, R
Hedehus, L
Liu, D
Huang, C
Vierbuchen, T
Sawyers, CL
Helin, K
Lin, Y
Islam, MT
Koche, R
Hedehus, L
Liu, D
Huang, C
Vierbuchen, T
Sawyers, CL
Helin, K
Document Type
Journal Article
Date
2023-07-20
Date Accepted
2023-06-05
Abstract
Nuclear receptor-binding SET-domain protein 1 (NSD1), a methyltransferase that catalyzes H3K36me2, is essential for mammalian development and is frequently dysregulated in diseases, including Sotos syndrome. Despite the impacts of H3K36me2 on H3K27me3 and DNA methylation, the direct role of NSD1 in transcriptional regulation remains largely unknown. Here, we show that NSD1 and H3K36me2 are enriched at cis-regulatory elements, particularly enhancers. NSD1 enhancer association is conferred by a tandem quadruple PHD (qPHD)-PWWP module, which recognizes p300-catalyzed H3K18ac. By combining acute NSD1 depletion with time-resolved epigenomic and nascent transcriptomic analyses, we demonstrate that NSD1 promotes enhancer-dependent gene transcription by facilitating RNA polymerase II (RNA Pol II) pause release. Notably, NSD1 can act as a transcriptional coactivator independent of its catalytic activity. Moreover, NSD1 enables the activation of developmental transcriptional programs associated with Sotos syndrome pathophysiology and controls embryonic stem cell (ESC) multilineage differentiation. Collectively, we have identified NSD1 as an enhancer-acting transcriptional coactivator that contributes to cell fate transition and Sotos syndrome development.
Citation
Molecular Cell, 2023, 83 (14), pp. 2398 - 2416.e12
Source Title
Molecular Cell
Publisher
CELL PRESS
ISSN
1097-2765
eISSN
1097-4164
1097-4164
1097-4164
Collections
Research Team
CEO Office